Tin mesoporphyrin clinical trials
Also written Stannsoporfin.
How each study uses tin mesoporphyrin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 1998 (2)
| Year | Studies |
|---|---|
| 1993 | 1 |
| 1997 | 1 |
| 1998 | 2 |
| 1999 | 2 |
| 2002 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 6
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company (4) · National Center for Research Resources (NCRR) (4) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses tin mesoporphyrin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- Stannsoporfin With Light Therapy for Newborn Babies With JaundiceCompletedPhase 2InfaCare Pharmaceuticals Corporation, a Mallinckrodt CompanyNCT01887327Written as StannsoporfinHow we know
- A Safety and Efficacy Trial of Stannsoporfin in Neonates With HyperbilirubinemiaTerminatedPhase 2InfaCare Pharmaceuticals Corporation, a Mallinckrodt CompanyNCT00850993Written as StannsoporfinHow we know
- Efficacy and Safety of Stannsoporfin in NeonatesCompletedPhase 3InfaCare Pharmaceuticals Corporation, a Mallinckrodt CompanyNCT02685137Written as stannsoporfinHow we know
- Safety and Pharmacology of StanateCompletedPhase 2InfaCare Pharmaceuticals Corporation, a Mallinckrodt CompanyNCT00115544Written as StanateHow we know
- Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature NewbornsCompletedPhase 2Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT00004382Written as tin mesoporphyrinHow we know
- Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute PorphyriaCompletedPhase 1/2National Center for Research Resources (NCRR)NCT00004789Written as tin mesoporphyrinHow we know
- Phase II Randomized Study of Tin Mesoporphyrin for Neonatal HyperbilirubinemiaCompletedPhase 2Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT00004381Written as tin mesoporphyrinHow we know
- Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute PorphyriasCompletedPhase 2National Center for Research Resources (NCRR)NCT00004396Written as tin mesoporphyrinHow we know
- Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of PorphyriaCompletedPhase 1National Center for Research Resources (NCRR)NCT00004397Written as tin mesoporphyrinHow we know
- Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of PorphyriaCompletedPhase 1National Center for Research Resources (NCRR)NCT00004398Written as tin mesoporphyrinHow we know
Codes
What other systems call tin mesoporphyrin · ClinicalTrials.gg INT003370
- MeSH (NLM) C055421tin mesoporphyrinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 0KAE1U0G7QSTANNSOPORFINConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C055421 | tin mesoporphyrin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 0KAE1U0G7Q | STANNSOPORFIN | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.